CDC91LI (PIG-U) is a newly discovered oncogene in human bladder cancer

Nature Medicine

Volumn 10, Issue 4, 2004, Pages 374-381

  Guo, Zhongmin ^a   Linn, Jürgen F ^a   Wu, Guojun ^a   Anzick, Sarah L ^b   Eisenberger, Claus F ^a   Halachmi, Sarel ^a   Cohen, Yoram ^a   Fomenkov, Alexey ^a   Hoque, Mohammad Obaidul ^a   Okami, Kenji ^a   Steiner, Gabriel ^a   Engles, James M ^a   Osada, Motonabu ^a   Moon, Chulso ^a   Ratovitski, Edward ^a   Trent, Jeffrey M ^b   Meltzer, Paul S ^b   Westra, William H ^a   Kiemeney, Lambertus A ^c   Schoenberg, Mark P ^d   Sidransky, David ^a   Trink, Barry ^a   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL; STAT3 PROTEIN; UROKINASE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CELL LINE; EPITHELIUM CELL; GENE AMPLIFICATION; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR; UPREGULATION; WART VIRUS; ANIMAL; BLADDER TUMOR; CELL STRAIN 3T3; CHROMOSOME 20; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; MOLECULAR CLONING; MOLECULAR GENETICS;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; SUS SCROFA;

ANIMALS; CHROMOSOMES, HUMAN, PAIR 20; CLONING, MOLECULAR; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; ONCOGENES; TRANSLOCATION, GENETIC; URINARY BLADDER NEOPLASMS;

EID: 11144356842     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1010     Document Type: Article

References (34)

1. Bishop, J.M. Molecular themes in oncogenesis. Cell 64, 235-248 (1991).
2. Weinberg, R.A. The molecular basis of oncogenes and tumor suppressor genes. Ann. NY Acad. Sci. 758, 331-338 (1995).
3. Weinberg, R.A. Oncogenes and tumor suppressor genes. CA Cancer J. Clin. 44, 160-170 (1994).
4. Dalla-Favera, R., Martinotti, S., Gallo, R.C., Erikson, J. & Croce, C.M. Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science 219, 963-967 (1983).
5. Dalla-Favera, R. et al. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA 79, 7824-7827 (1982).
6. Kallioniemi, O.P. et al. Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors. Semin. Cancer Biol. 4, 41-46 (1993).
7. Wu, G. et al. Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors. Cancer Res. 61, 4951-4955 (2001).
8. Wu, G.J. et al. 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes, Cancer Res. 60, 5371-5375 (2000),
9. Kallioniemi, A. et al. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer 12, 213-219 (1995).
10. Kallioniemi, A. et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. Natl. Acad. Sci. USA 91, 2156-2160 (1994).
11. Muleris, M., Almeida, A., Gerbault-Seureau, M., Malfoy, B. & Dutrillaux, B. Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique. Genes Chromosomes Cancer 10, 160-170 (1994).
12. Forozan, F. et al. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res. 60, 4519-4525 (2000).
13. Guan, X.Y. et al. Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer. Cancer Res. 56, 3446-3450 (1996).
14. Savelieva, E. et al. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroelpithelial cells. Oncogene 14, 551-560 (1997).
15. Wimmer, K. et al. Co-amplification of a novel gene, NAG, with the N-myc gene in neuroblastoma. Oncogene 18, 233-238 (1999).
16. Pollack, J.R. et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl. Acad. Sci. USA 99, 12963-12968 (2002).
17. Anzick, S.L. et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277, 965-968 (1997).
18. Mu, D. et al Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell 3, 297-302 (2003).
19. Maguire, R.T., Robins, T.S., Thorgeirsson, S.S. & Heilman, C.A. Expression of cellular myc and mos genes in undifferentiated B cell lymphomas of Burkitt and non-Burkitt types. Proc. Natl. Acad. Sci. USA 80, 1947-1950 (1983).
20. Grieco, M. et al. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60, 557-563 (1990).
21. Schoenberg, M., Kiemeney, L., Walsh, P.C., Griffin, C.A. & Sidransky, D. Germline translocation t(5;20)(p15;q11) and familial transitional cell carcinoma. J. Urol. 155, 1035-1036 (1996).
22. Hong, Y. et al. Human PIG-U and yeast Cdc91p are the fifth subunit of GPI transamidase that attaches GPI-anchors to proteins. Mol. Biol. Cell 14, 1780-1789 (2003).
23. Okamura, S. et al. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol. Cell 18, 85-94 (2001).
24. Memarzadeh, S. et al. Urokinase plasminogen activator receptor: prognostic biomarker for endometrial cancer. Proc. Natl. Acad. Sci. USA 99, 10647-10652 (2002).
25. Dumler, I. et al. The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. J. Biol. Chem. 273, 315-321 (1998).
26. Yeager, T.R. et al. Overcoming cellular senescence in human cancer pathogenesis. Genes Dev. 12, 163-174 (1998).
27. Tanner, M.M. et al. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res. 54, 4257-4260 (1994).
28. Fukushige, S. et al. Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosomes Cancer 19, 161-169 (1997).
29. Tanner, M.M. et al. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res. 56, 3441-3445 (1996).
30. Fitzgerald, J.M. et al. Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors. J. Natl. Cancer Inst. 87, 129-133 (1995).
31. Hovey, R.M. et al. Genetic alterations in primary bladder cancers and their metastases. Cancer Res. 58, 3555-3560 (1998).
32. Bringuier, P.P., Tamimi, Y., Schuuring, E. & Schalken, J. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. Oncogene 12, 1747-1753 (1996).
33. Friedmann, E., Salzberg, Y., Weinberger, A., Shaltiel, S. & Gerst, J.E. YOS9, the putative yeast homolog of a gene amplified in osteosarcomas, is involved in the endoplasmic reticulum (ER)-Golgi transport of GPI-anchored proteins. J. Biol. Chem. 277, 35274-35281 (2002).
34. Blasi, F. & Carmeliet, P. uPAR: a versatile signalling orchestrator. Nat. Rev. Mol. Cell. Biol. 3, 932-943 (2002).